6370 LUSK BLVD., SAN DIEGO, CA
Reports Second Quarter 2026 Financial Results
BlossomHill Therapeutics Updates on SOLARA Trial Results for BH-30643 in NSCLC
Amendment and Restatement of Certificate of Incorporation and Bylaws
Q2
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
No filings found
Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-1MEF